Table 1 Characteristics of patients who underwent vitreoretinal surgery in sub-Tenon and general anesthesia
Characteristics | Sub-Tenon anesthesia (N = 33/67) | General anesthesia (N = 34/67) | P value |
|---|---|---|---|
Age (years) | 72.9 ± 9.1 (59.0–91.0) | 65.4 ± 8.6 (51.0–80.0) | 0.002* |
Sex | 0.305 | ||
Male | 20 (60.6%) | 25 (73.5%) | |
Female | 13 (39.4%) | 9 (26.5%) | |
Eye | > 0.999 | ||
Right eye | 14 (42.4%) | 15 (44.1%) | |
Left eye | 19 (57.6%) | 19 (55.9%) | |
Lens | < 0.001* | ||
Phakic | 1 (3.0%) | 13 (38.2%) | |
Pseudophakic | 32 (97.0%) | 21 (61.8%) | |
Time between IOL implantation and vitreoretinal surgery (years) | 3.7 ± 2.8 (0.3–11.0) | 3.3 ± 3.1 (0.5–11.0) | 0.961 |
BCVA (logMAR) | |||
Pre surgery | 1.23 ± 0.92 (NL-0.22) | 0.89 ± 0.70 (3.00–0.22) | 0.107 |
Follow-up | 0.89 ± 0.95 (NL-0.00) | 0.86 ± 1.14 (3.00–0.22) | 0.938 |
Surgery duration (minutes) | 22.7 ± 8.6 (12.0–59.0) | 32.6 ± 15.1 (13.0–67.0) | 0.002* |
Indication for surgery | |||
Rhegmatogenous RD | 6 (18.2%) | 16 (47.1%) | |
Macular hole/Gliosis/VMT | 4 (12.1%) | 6 (17.6%) | |
Silicone oil removal | 13 (39.4%) | 6 (17.6%) | |
Silicone oil removal + peeling | 2 (6.1%) | 0 | |
Vitreous hemorrhage | 6 (18.2%) | 4 (11.8%) | |
Endophthalmitis | 1 (3.0%) | 0 | |
Sub-ILM hemorrhage | 1 (3.0%) | 1 (2.9%) | |
CRVO | 0 | 1 (2.9%) | |
Adverse events during follow-up | 0.709 | ||
RD | 2 (6.1%) | 2 (5.9%) | |
Vitreous hemorrhage | 1 (3.0%) | 0 | |
PVR | 1 (3.0%) | 1 (2.9%) | |